Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
D. Elliman, H. Bedford.
Safety and efficacy of combination vaccines. Combinations reduce distress and are efficacious and safe.
Bmj, 326 (2003), pp. 995-996
[2.]
S.H. Yeh, J.I. Ward.
Strategies for development of combination vaccines.
Pediatr Infect Dis J, 20 (2001), pp. S5-S9
[3.]
F.A. Moraga Llop.
Vacunas combinadas hexavalentes.
An Pediatr (Barc), 58 (2003), pp. 33-40
[4.]
Centers for Disease Control and Prevention.
Combination vaccines for childhood immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy oh Family Physicians (AAFP).
Mmwr, 48 (1999), pp. 1-12
[5.]
M.D. Decker, K.M. Edwards.
Combination vaccines: Problems and promise.
J Pediatr, 137 (2000), pp. 291-295
[6.]
F.A. Moraga Llop.
Compliance with vaccination schedules: How many shots are too many?.
Vaccines: Children & Practice, 5 (2002), pp. 43-45
[7.]
Comité Asesor de Vacunas de la Asociación Española de Pediatría.
El título de anticuerpos, la memoria inmunológica y la eficacia protectora de la vacuna frente a Haemophilus influenzae tipo b.
An Esp Pediatr, 50 (1999), pp. 341-345
[8.]
F. Zepp, H.J. Schmitt, A. Kaufhold, A. Schuind, M. Knuf, P. Habermehl, et al.
Evidence for induction of polysaccharide specific B-cell memory in the 1st year of life: Plain Haemophilus influenzae type b-pRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTP-HBV combined vaccine.
Eur J Pediatr, 156 (1997), pp. 18-24
[9.]
E. Mallet, P. Fabre, E. Pines, H. Salomon, T. Staud, F. Schödel, et al.
Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants.
Pediatr Infect Dis J, 19 (2000), pp. 1119-1127
[10.]
H. Schmitt, M. Knuf, E. Ortiz, R. Sänger, M.C. Uwamwezi, A. Kaufhold.
Primary vaccination of infants with diphtheria-tetanus-acellular- pertussis-hepatitis B virus-inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections.
J Pediatr, 137 (2000), pp. 304-312
[11.]
The European Agency for the Evaluation of Medicinal Products. EMEA reviews hexavalent vaccines: Hexavac and Infanrix Hexa. 28 April 2003. http://www.emea.eu.int/pdfs/human/press/pus/851903en.pdf
[12.]
J. Marès Bermúdez.
Interacciones entre las vacunas durante el primer año de vida.
2.° Congreso Nacional de la Asociación Española de Vacunología. Ponencias, pp. 59-70
[13.]
The European Agency for the Evaluation of Medicinal Products. EMEA update on hexavalent vaccines: Hexavac and Infanrix Hexa. 01 December 2003. http://www.emea.eu.int/pdfs/human/press/pus/851903en.pdf
[14.]
Ministerio de Sanidad y Consumo.
Agencia Española del Medicamento.
Buenas Prácticas de Farmacovigilancia del Sistema Español de Farmacovigilancia, pp. 10
Copyright © 2004. Asociación Española de Pediatría
